Intravitreal bevacizumab injection alone or combined with macular photocoagulation compared to macular photocoagulation as primary treatment of diabetic macular edema | Zendy

Sandra Jovanović | Zendy; Vladimir Čanadanović | Zendy; Ana Sabo | Zendy; Z Grgić | Zendy; Milena Mitrović | Zendy; Dušan Rakić | Zendy

Open Access

Intravitreal bevacizumab injection alone or combined with macular photocoagulation compared to macular photocoagulation as primary treatment of diabetic macular edema

Author(s) -

Sandra Jovanović,

Vladimir Čanadanović,

Ana Sabo,

Z Grgić,

Milena Mitrović,

Dušan Rakić

Publication year - 2015

Publication title -

vojnosanitetski pregled

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.123

H-Index - 19

eISSN - 2406-0720

pISSN - 0042-8450

DOI - 10.2298/vsp140402074j

Subject(s) - medicine , bevacizumab , ophthalmology , diabetic retinopathy , visual acuity , macular edema , diabetic macular edema , laser coagulation , diabetes mellitus , surgery , chemotherapy , endocrinology

Within diabetic retinopathy (DR), diabetic macular edema DIE) is one of the leading causes of the loss of visual acuity. The aim of this study was to determine the efficacy of the intravitreal vascular endothelial growth factor (VEGF) inhibitor application alone or combined with macular focal/grid lasephotocoagulation compared with laser treatment alone.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research